Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs34478148 | chr3:150897403 | A/G | 0.000439 | 170 | 24.7 | 29.43 | 60.03 | KM Plot |
PCPG | rs34535387 | chr14:74314747 | C/T | 9.6E-6 | 178 | 25.47 | 28.3 | 10.3 | KM Plot |
PCPG | rs34539488 | chr17:50334160 | A/G | 0.00028 | 170 | 26.12 | 28.38 | 16.33 | KM Plot |
PCPG | rs34539781 | chr16:89955230 | C/T | 0.000157 | 176 | 25.77 | 21.5 | 36.37 | KM Plot |
PCPG | rs34540362 | chr2:242531133 | G/A | 4.02E-5 | 178 | 25.87 | 27.27 | 20.2 | KM Plot |
PCPG | rs34547187 | chr16:1770603 | C/T | 0 | 172 | 25.6 | 19.3 | 2.93 | KM Plot |
PCPG | rs34562978 | chr12:53502234 | TA/T | 1.19E-10 | 174 | 25.08 | 27.08 | 3.05 | KM Plot |
PCPG | rs34574834 | chr4:78951026 | T/TG | 0 | 173 | 2.93 | 25.43 | 25.28 | KM Plot |
PCPG | rs34578331 | chr22:29347215 | G/T | 0.000387 | 174 | 24.85 | 27.87 | 33.77 | KM Plot |
PCPG | rs34587485 | chr14:74308298 | C/T | 4.2E-6 | 175 | 25.47 | 27.2 | 10.43 | KM Plot |
PCPG | rs34602793 | chr17:50300935 | G/A | 6.47E-5 | 177 | 25.53 | 28.38 | 14.47 | KM Plot |
PCPG | rs34604714 | chr16:89948985 | A/G | 0.000157 | 176 | 25.77 | 21.5 | 36.37 | KM Plot |
PCPG | rs34606253 | chr2:61582738 | A/C | 6.43E-5 | 178 | 23.43 | 29.88 | 10.3 | KM Plot |
PCPG | rs34626694 | chr17:50260366 | C/T | 4.67E-5 | 171 | 25.77 | 28.47 | 14.43 | KM Plot |
PCPG | rs34629155 | chr12:26881800 | G/A | 8.77E-5 | 178 | 24.3 | 28.47 | 5.97 | KM Plot |